Diabetes and cancer

Vigneri, Paolo, Frasca, Francesco, Sciacca, Laura, Pandini, Giuseppe, Vigneri, Riccardo·2009·Endocrine Related Cancer

Cited by (1,000)

Items 101–200 of 1,000

  1. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
    Shuwen Dong, Zheng Wang, Kunwei Shen, Xiaosong Chen · 2021 · Frontiers in Oncology
  2. Obesity and Bone Health: A Complex Relationship
    Ana Piñar-Gutiérrez, Cristina García‐Fontana, Beatriz García-Fontana, Manuel Muñoz‐Torres · 2022 · International Journal of Molecular Sciences
  3. Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
    Hu, Weiting, Song, Rui, Cheng, Rui, Liu, Caihong, Guo, Rui, Tang, Wei, Zhang, Jie, Zhao, Qian, Li, Xing, Liu, Jing · 2022 · Frontiers in Endocrinology
  4. Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
    Øystein Karlstad, Jakob Starup‐Linde, Peter Vestergaard, Vidar Hjellvik, Marloes T. Bazelier, Marjanka K. Schmidt, Morten Andersen, Anssi P. Auvinen, Jari K. Haukka, Kari Furu et al. · 2013 · Current Drug Safety
  5. Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway
    Andréia Vasconcelos-dos-Santos, Hector F.B.R. Loponte, Natália Rodrigues Mantuano, Isadora de Araújo Oliveira, Iron F. De Paula, Leonardo K. Teixeira, Julio Cesar Madureira de‐Freitas‐Junior, Katia Calp Gondim, Norton Heise, Ronaldo Mohana‐Borges et al. · 2017 · Oncogenesis
  6. The association of micronucleus frequency with obesity, diabetes and cardiovascular disease
    Maria Grazia Andreassi, Roberto Barale, Patricia Iozzo, Eugenio Picano · 2010 · Mutagenesis
  7. Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants
    Jenkins, David J A, Willett, Walter C, Yusuf, Salim, Hu, Frank B, Glenn, Andrea J, Liu, Simin, Mente, Andrew, Miller, Victoria, Bangdiwala, Shrikant I, Gerstein, Hertzel C et al. · 2024 · The Lancet Diabetes & Endocrinology
  8. GLP‐1 based therapies: differential effects on fasting and postprandial glucose
    Mark S. Fineman, Brenda B. Cirincione, David G. Maggs, Michaëla Diamant · 2012 · Diabetes Obesity and Metabolism
  9. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
    Gianluca Perseghin, Giliola Calori, Guido Lattuada, Francesca Ragogna, Erika Dugnani, Maria Paola Garancini, Paolo Crosignani, Marco Villa, Emanuele Bosi, Giacomo Ruotolo et al. · 2012 · Acta Diabetologica
  10. Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications.
    N. Stefan, H. Häring, F. Hu, M. Schulze · 2016 · The Lancet Diabetes and Endocrinology
  11. A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time
    Hulda Hrund Björnsdóttir, Araz Rawshani, Aidin Rawshani, Stefan Franzén, Ann‐Marie Svensson, Naveed A. Sattar, Soffia Guðbjörnsdóttir · 2020 · Scientific Reports
  12. Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
    Matteo Monami, Claudia Colombi, Daniela Balzi, Ilaria Dicembrini, Stefano Giannini, Cecilia Melani, Valentina Vitale, Desiderio Romano, Alessandro Barchielli, Niccolò Marchionni et al. · 2010 · Diabetes Care
  13. Diabetes mellitus and risk of prostate cancer in the EuropeanProspectiveInvestigation into Cancer and Nutrition
    Konstantinos K. Tsilidis, Naomi E. Allen, Paul N. Appleby, Sabine Rohrmann, Ute Nöthlings, Larraitz Arriola, Marc James Gunter, Véronique Chajès, Sabina Rinaldi, Isabelle Romieu et al. · 2014 · International Journal of Cancer
  14. Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
    Rikje Ruiter, Loes E. Visser, Myrthe P. P. van Herk‐Sukel, J.W.W. Coebergh, Harm Reinout Haak, Petronella H.L.M. Geelhoed-Duijvestijn, Sabine M. J. M. Straus, Ron M. C. Herings, Bruno H. Ch. Stricker · 2011 · Diabetologia
  15. Insulin and its analogues and their affinities for the IGF1 receptor
    Aimee J. Varewijck, J. A. M. J. L. Janssen · 2012 · Endocrine Related Cancer
  16. Insulin Resistance: The Increased Risk of Cancers
    Leszek Szablewski · 2024 · Current Oncology
  17. From tumor cell metabolism to tumor immune escape
    Martín Villalba, Moeez Ghani Rathore, Nuria López-Royuela, Ewelina Krzywińska, Johan Garaude, Nerea Allende-Vega · 2012 · The International Journal of Biochemistry & Cell Biology
  18. Plasma-free amino acid profiles are predictors of cancer and diabetes development
    Xinyan Bi, Christiani Jeyakumar Henry · 2017 · Nutrition and Diabetes
  19. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts
    Yanan Ma, Wanshui Yang, Mingyang Song, Stephanie A. Smith‐Warner, Juhong Yang, Yanping Li, Wenjie Ma, Yang Hu, Shuji Ogino, Frank B. Hu et al. · 2018 · British Journal of Cancer
  20. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients
    Laura Sciacca, Riccardo Vigneri, Andrea Tumminia, Francesco Frasca, Sebastiano Squatrito, Lucia Frittitta, Paolo Giovanni Vigneri · 2013 · Nutrition Metabolism and Cardiovascular Diseases
  21. Associations Between General and Abdominal Adiposity and Mortality in Individuals With Diabetes Mellitus
    Diewertje Sluik, Heiner Boeing, Jukka Montonen, Tobias Pischon, Rudolf Kaaks, Brigit Teucher, Anne Marie Tjønneland, Jytte Halkjær, Tina Landsvig Berentzen, Kim Overvad et al. · 2011 · American Journal of Epidemiology
  22. A general mechanism for conditional expression of exaggerated sexually‐selected traits
    Ian A. Warren, Hiroki Gotoh, Ian M. Dworkin, Douglas J. Emlen, Laura Corley Lavine · 2013 · BioEssays
  23. Association between markers of glucose metabolism and risk of colorectal cancer
    Jinming Xu, Ye Yao, Han Wu, Penelope J. Duerksen-Hughes, Honghe Zhang, Peiwei Li, Jian Huang, Jun Jie Yang, Yihua Wu, Dajing Xia · 2016 · BMJ Open
  24. Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysis
    Shahid Mahmood, Robert J. MacInnis, Dallas R. English, Amalia Karahalios, Brigid Mary Lynch · 2017 · International Journal of Epidemiology
  25. Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping Review
    Elsa Vitale, Alessandro Rizzo, Kazuki Santa, Emilio Jirillo · 2024 · Biology
  26. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights
    Ntsoaki Annah Nyane, Thabiso Bethwel Tlaila, Tanki Gabriel Malefane, Duduzile Edith Ndwandwe, Peter Mark Oroma Owira · 2017 · European Journal of Pharmacology
  27. Proinsulin Binds with High Affinity the Insulin Receptor Isoform A and Predominantly Activates the Mitogenic Pathway
    Roberta Malaguarnera, Antonella Sacco, Concetta Voci, Giuseppe Pandini, Riccardo Vigneri, Antonino Belfiore · 2012 · Endocrinology
  28. Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies
    Mukete Franklin Sona, Seung‐Kwon Myung, Keeho Park, Jargalsaikhan Galsuren · 2018 · Japanese Journal of Clinical Oncology
  29. Cross-talk between Insulin and Wnt Signaling in Preadipocytes
    Palsgaard, Jane, Emanuelli, Brice, Winnay, Jonathon N., Sumara, Grzegorz, Karsenty, Gerard, Kahn, C. Ronald · 2012 · Journal of Biological Chemistry
  30. Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer
    Yves Lecarpentier, VICTOR A. CLAES, Alexandre Vallée, Jean‐Louis Hébert · 2017 · PPAR Research
  31. Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes
    Kasper Broedbaek, Allan Weimann, Elisabeth Specht Stovgaard, Henrik Enghusen Poulsen · 2011 · Free Radical Biology and Medicine
  32. The Insulin Receptor: A New Target for Cancer Therapy
    Roberta Malaguarnera, Antonino Belfiore · 2011 · Frontiers in Endocrinology
  33. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
    Mei‐Yueh Lee, Kun‐Der Lin, Pi‐Jung Hsiao, Shyi‐Jang Shin · 2011 · Metabolism
  34. Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population
    Amikar Sehdev, Ya‐Chen Tina Shih, Benjamin G. Vekhter, Marc B. Bissonnette, Olufunmilayo Ibironke Olopade, Blasé N. Polite · 2014 · Cancer
  35. Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
    Harold E. Lebovitz · 2011 · Diabetes Care
  36. Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder
    Byung Hyo Cha · 2011 · World Journal of Gastroenterology
  37. The impact of diabetes on survival in women with ovarian cancer
    Arvind Bakhru, Ronald J. Buckanovich, Jennifer J. Griggs · 2011 · Gynecologic Oncology
  38. The Antidiabetic Activity ofNigella sativaand Propolis on Streptozotocin‐Induced Diabetes and Diabetic Nephropathy in Male Rats
    Haddad A. El Rabey, Madeha N. Al‐Seeni, Amal S. Bakhashwain · 2017 · Evidence-based Complementary and Alternative Medicine
  39. Selenium Supranutrition: Are the Potential Benefits of Chemoprevention Outweighed by the Promotion of Diabetes and Insulin Resistance?
    Caroline R.B. Rocourt, Wen‐Hsing Cheng · 2013 · Nutrients
  40. Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation
    Yuanying Gong, Yufang Ma, Maksim Sinyuk, Sudan N. Loganathan, Reid C. Thompson, Jann Nagina Sarkaria, Wenbiao Chen, Justin Durla Lathia, Bret C. Mobley, Stephen W. Clark et al. · 2015 · Neuro-Oncology
  41. Diabetes Mellitus Increases the Risk of Bladder Cancer: An Updated Meta-Analysis of Observational Studies
    Hong Fang, Baodong Yao, Yujie Yan, Huilin Xu, Yinan Liu, Hongmei Tang, Jie Zhou, Lili Cao, Weijie Wang, Jinling Zhang et al. · 2013 · Diabetes Technology & Therapeutics
  42. Type 2 diabetes mellitus and colorectal cancer: Meta-analysis on sex-specific differences
    Heike U. Krämer, Ben Schöttker, Elke Raum, Hermann Brenner · 2011 · European Journal of Cancer
  43. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
    Dorothee M. Baur, Jens Klotsche, Ole‐Petter R. Hamnvik, Caroline Sievers, Lars Pieper, Hans‐Ulrich Wïttchen, Günter Karl Stalla, Roland Michael Schmid, Stefanos N. Kales, Christos Socrates Mantzoros · 2010 · Metabolism
  44. Type 2 Diabetes and Cancer: What Is the Connection?
    Dara Cannata, Yvonne Fierz, Archana Vijayakumar, Derek LeRoith · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  45. Potential Efficacy of Broccoli Sprouts as a Unique Supplement for Management of Type 2 Diabetes and Its Complications
    Zahra Bahadoran, Parvin Mirmiran, Fereidoun Azizi · 2013 · Journal of Medicinal Food
  46. Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies
    Cristina Bosetti, Valentina Rosato, Jerry Polesel, Fabio Levi, Renato Talamini, Maurizio Montella, Eva Negri, Alessandra Tavani, Antonella Zucchetto, Silvia Franceschi et al. · 2012 · Nutrition and Cancer
  47. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
    Charupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, Sopit Wongkham · 2016 · Scientific Reports
  48. Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
    Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, Tomotaka Ugai, Shinichi Yachida, Shuji Ogino · 2022 · Gut
  49. Quantitative Analysis of Pancreatic Polypeptide Cell Distribution in the Human Pancreas
    Xiaojun Wang, Mark C. Zielinski, Ryosuke Misawa, Patrick Wen, Tian-Yuan Wang, Chengzhang Wang, Piotr Witkowski, Manami Hara · 2013 · PLoS ONE
  50. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors
    Adedayo A. Onitilo, Jessica Marie Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A.R. Doi · 2012 · Cancer Causes & Control
  51. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
    Simona Bo, Giovannino Ciccone, Rosalba Rosato, Paola Villois, Giovanni Appendino, Ezio Ghigo, Giorgio Grassi · 2011 · Diabetes Obesity and Metabolism
  52. Latest insights into the risk of cancer in diabetes
    Hiroshi Noto, Atsushi Goto, Tetsuro Tsujimoto, Keiichiro Osame, Mitsuhiko Noda · 2013 · Journal of Diabetes Investigation
  53. Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
    Elena Pavlova Filipova, Katya Hristova Uzunova, Krassimir Kalinov, Toni Yonkov Vekov · 2017 · Diabetes Therapy
  54. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
    Ahmed Olatunde, Manisha Nigam, RAHUL KUNWAR SINGH, Abhaya Shikhar Panwar, Abdulwahab Lasisi, Fahad Abdulrahman Alhumaydhi, Vijay Kumar, Abhay Prakash Mishra, Javad Sharifi‐Rad · 2021 · Cancer Cell International
  55. Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies
    Isabelle N Colmers-Gray, Samantha L. Bowker, Lisa Tjosvold, Jeffrey A. Johnson · 2012 · Diabetes & Metabolism
  56. Type 2 Diabetes and Breast Cancer: The Interplay Between Impaired Glucose Metabolism and Oxidant Stress
    Ferroni, Patrizia, Riondino, Silvia, Buonomo, Oreste, Palmirotta, Raffaele, Guadagni, Fiorella, Roselli, Mario · 2015 · Oxidative Medicine and Cellular Longevity
  57. A New Approach for Diagnosis of Diabetes and Prediction of Cancer Using ANFIS
    C. Kalaiselvi, G. M. Nasira · 2014 · World Congress on Computing and Communication Technologies (WCCCT)
  58. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
    Sui‐Foon Lo, Shih‐Ni Chang, Chih‐Hsin Muo, Shih‐Yin Chen, Fang‐Yin Liao, Shu‐Wei Dee, Pei‐Chun Chen, Fung‐Chang Sung · 2012 · International Journal of Cancer
  59. PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
    Veronica Vella, Maria Luisa Nicolosi, Stefania Giuliano, Maria Bellomo, Antonino Belfiore, Roberta Malaguarnera · 2017 · Frontiers in Endocrinology
  60. Report of the J apan Diabetes Society/ J apanese Cancer Association joint committee on diabetes and cancer
    Masato Kasuga, Kohjiro Ueki, Naoko Tajima, Mitsuhiko Noda, Ken Ohashi, Hiroshi Noto, Atsushi Goto, Wataru Ogawa, Ryuichi Sakai, Shoichiro Tsugane et al. · 2013 · Cancer Science
  61. A Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer Patients
    Yusook Jeong, Hye Sook Han, Hyo Duk Lee, Jiyoul Yang, Jiwon Jeong, Moon Ki Choi, Jihyun Kwon, Hyun‐Jung Jeon, Taekeun Oh, Ki Hyeong Lee et al. · 2016 · Cancer Research and Treatment
  62. Dietary components and risk of cardiovascular disease and all-cause mortality: a review of evidence from meta-analyses
    Chun Shing Kwok, Martha Gulati, Erin D. Michos, Jessica E. Potts, Pensée Wu, Lorraine Watson, Yoon Kong Loke, Christian David Mallen, Mamas A. Mamas · 2019 · European Journal of Preventive Cardiology
  63. Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia
    Z. Racil, Filip Rázga, J. Drápalová, Lucie Burešová, Daniela Žáčková, Martina Palacková, Lukáš Semerád, Ludmila Malášková, Martin Haluzı́k, Jiřı́ Mayer · 2013 · Haematologica
  64. Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies
    Zhi‐Feng Miao, Hao Xu, Ying-Ying Xu, Zhen-ning Wang, Tingting Zhao, Yongxi Song, Huimian Xu · 2017 · Oncotarget
  65. Diabetes and risk of bladder cancer
    Todd A. MacKenzie, Michael S. Zens, Assiamira M. Ferrara, Alan R. Schned, Margaret Rita Karagas · 2010 · Cancer
  66. Metformin: The hidden chronicles of a magic drug
    Khalid Mahmood, Muhammad Naeem, Nasir Ali Rahimnajjad · 2012 · European Journal of Internal Medicine
  67. Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to Lifestyle
    Ahmad H. AlKhatib, Catherine Tsang, Jaakko O. Tuomilehto · 2018 · International Journal of Molecular Sciences
  68. Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators
    Daniel Bedinger, Sean H. Adams · 2015 · Molecular and Cellular Endocrinology
  69. Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China
    Pian-hong Zhang, Zhongwen Chen, Duo Lv, Yuyang Xu, Weiling Gu, Xuhui Zhang, Yuan-luo Le, Honghong Zhu, Yimin Zhu · 2012 · BMC Public Health
  70. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases
    Ganji Purnachandra Nagaraju, Syed Farhan Zafar, Bassel F. El‐Rayes · 2013 · Nutrition Reviews
  71. Cancer risk in patients with type 2 diabetes mellitus and their relatives
    Xiangdong Liu, Kari Hemminki, Asta Försti, Kristina Sundquist, Jan Sundquist, Jianguang Ji · 2015 · International Journal of Cancer
  72. Diabetes mellitus and the risk of bladder cancer
    Yongping Xu, Rui Huo, Xi Chen, Xuefeng Yu · 2017 · Medicine
  73. Introduction
    Robyn L. Houlden · 2018 · Canadian Journal of Diabetes
  74. Metformin: prevention of genomic instability and cancer: a review
    Najafi, Masoud, Cheki, Mohsen, Rezapoor, Saeed, Geraily, Ghazale, Motevaseli, Elahe, Carnovale, Carla, Clementi, Emilio, Shirazi, Alireza · 2018 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  75. Metformin and Breast Cancer: Molecular Targets
    João Faria, Gonçalo de Câmara Negalha, Ana Azevedo, Fátima Martel · 2019 · Journal of Mammary Gland Biology and Neoplasia
  76. Role of Metformin in Suppressing 1,2-Dimethylhydrazine-Induced Colon Cancer in Diabetic and Non-Diabetic Mice: Effect on Tumor Angiogenesis and Cell Proliferation
    Dalia K. Zaafar, Sawsan A. Zaitone, Yasser M. Moustafa · 2014 · PLoS ONE · Retracted
  77. The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies
    Yongbo Wang, P. Yan, Tao Fu, Jingping Yuan, G. Yang, Yanfei Liu, Z.-J. Zhang · 2020 · Diabetes & Metabolism
  78. Cancer Biology and Prevention in Diabetes
    Swayam Prakash Srivastava, Julie E. Goodwin · 2020 · Cells
  79. Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
    Zhaowei Zhu, Xiaohua Zhang, Zhoujun Shen, Shan Zhong, Xianjin Wang, Yingli Lu, Xu Chen · 2013 · PLoS ONE
  80. Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk
    Sho‐ichi Yamagishi, Takanori Matsui, Kei Fukami · 2014 · Rejuvenation Research
  81. Hyperinsulinemia Drives Epithelial Tumorigenesis by Abrogating Cell Competition
    Yuya Sanaki, Rina Nagata, Daisuke Kizawa, Pierre Léopold, Tatsushi Igaki · 2020 · Developmental Cell
  82. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
    Mónica Enguita‐Germán · 2014 · World Journal of Hepatology
  83. Macrophages and T cells in metabolic disorder-associated cancers
    Daniel Taranto, D. Kloosterman, L. Akkari · 2024 · Nature Reviews. Cancer
  84. Effects of Sulfonylureas on Tumor Growth: A Review of the Literature
    Giulia Pasello, Loredana Urso, PierFranco Conte, Adolfo Gino Favaretto · 2013 · The Oncologist
  85. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease
    Pamela Minicozzi, Franco Berrino, Federica Sebastiani, Fabio Falcini, Rosa Vattiato, Francesca Cioccoloni, Gioia Calagreti, Mario Fusco, Maria Francesca Vitale, Rosario Tumino et al. · 2013 · European Journal of Cancer
  86. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
    Marco Gallo, Giovanna Muscogiuri, Francesco Felicetti, Antongiulio Faggiano, Francesco Trimarchi, Emanuela Arvat, Riccardo Vigneri, Annamaria Colao · 2017 · Metabolism
  87. The Global Burden of Diabetes
    Jessica L. Harding, Mary Beth Weber, Jonathan E. Shaw · 2024 · Wiley eBooks
  88. The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions
    Virmani, Ashraf, Pinto, Luigi, Bauermann, Otto, Zerelli, Saf, Diedenhofen, Andreas, Binienda, Zbigniew K., Ali, Syed F., van der Leij, Feike R. · 2015 · Molecular Neurobiology
  89. Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
    Lonneke Veronique van de Poll-Franse, Harm Reinout Haak, J.W.W. Coebergh, Maryska L.G. Janssen-Heijnen, V.E.P.P. Lemmens · 2012 · Diabetologia
  90. The Association between Diabetes Mellitus and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis
    Ting Chen, Delu Song, Guangliang Shan, Ke Wang, Yiwei Wang, Jin Ma, Yong Zhong · 2013 · PLoS ONE
  91. Type 2 diabetes mellitus—current therapies and the emergence of surgical options
    Harold E. Lebovitz · 2011 · Nature Reviews Endocrinology
  92. Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway
    Hongpeng Jiang, Qianqian Yao, Yongbo An, Linlin Fan, Jing Wang, Huiying Li · 2021 · Phytomedicine
  93. In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
    Zhan Qu, Yangde Zhang, Mingmei Liao, Yuxiang Chen, Jinfeng Zhao, Yifeng Pan · 2012 · Hepatology Research
  94. The Association Between Self-Reported Diabetes and Cancer Incidence in the NIH-AARP Diet and Health Study
    Gabriel Y. Lai, Yikyung Park, Patricia A. Hartge, Albert R. Hollenbeck, Neal D. Freedman · 2013 · The Journal of Clinical Endocrinology & Metabolism
  95. Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes
    Xilin Yang, Wing Yee So, Ronald C.W., Alice P.S. Kong, Heung Man Lee, Linda W.L. Yu, Chun‐Chung Chow, Risa Ozaki, Gary T C Ko, Juliana C.N. Chan · 2010 · Diabetes Care
  96. Incidence of Diabetes in Colorectal Cancer Survivors
    Simron Singh, Craig C. Earle, Sandy J. Bae, Hadas D. Fischer, Lingsong Yun, Peter C. Austin, Paula A. Rochon, George Anderson, Lorraine Lucille Lipscombe · 2016 · JNCI Journal of the National Cancer Institute
  97. High glucose levels promote the proliferation of breast cancer cells through GTPases
    Yilin Hou, Man Zhou, Jing Xie, Ping Chao, Qiyu Feng, Jun Wu · 2017 · Breast Cancer Targets and Therapy
  98. Mechanisms Involved in Childhood Obesity-Related Bone Fragility
    M. Faienza, G. D'Amato, M. Chiarito, G. Colaianni, S. Colucci, M. Grano, F. Corbo, G. Brunetti · 2019 · Frontiers in Endocrinology
  99. Temporal trends in population‐based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years
    Yuhree Kim, Aslam M. Ejaz, Amit Tayal, Gaya Spolverato, John F. P. Bridges, Robert A. Anders, Timothy Michael Pawlik · 2014 · Cancer
  100. Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
    Brandon L. Pierce · 2012 · Urologic Oncology Seminars and Original Investigations